Qualcomm Inc. (QCOM) Financials Nov 14, 2014, 7:56
Qualcomm Inc. (QCOM) Financials Nov 14, 2014, 7:56 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Qualcomm Inc.
Fiscal year is October-September. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 10.99B 14.96B 19.12B 24.87B 26.49B
Cost of Goods Sold (COGS) incl. D&A 3.52B 4.88B 7.1B 9.82B 10.69B
COGS excluding D&A 2.85B 3.82B 6.2B 8.8B 9.54B
Depreciation & Amortization Expense 666M 1.06B 900M 1.02B 1.15B
Depreciation 437M 704M 427M 515M 607M
Amortization of Intangibles 229M 357M 473M 502M 543M
Gross Income 7.47B 10.08B 12.03B 15.05B 15.8B
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 4.25B 4.92B 6.11B 7.49B 7.77B
Research & Development 2.55B 3B 3.92B 4.97B 5.48B
Other SG&A 1.7B 1.92B 2.19B 2.52B 2.29B
Other Operating Expense 0 0 0 0 0
Unusual Expense 60M 192M 234M 404M 826M
EBIT after Unusual Expense (60M) (192M) (234M) (404M) (826M)
Non Operating Income/Expense 405M 337M 369M 369M 999M
Non-Operating Interest Income 530M 500M 609M 697M 586M
Equity in Affiliates (Pretax) (4M) (7M) (9M) (6M) (10M)
Interest Expense 58M 114M 90M 23M 5M
Gross Interest Expense 58M 114M 90M 23M 5M
Interest Capitalized 0 0 0 - 0
Pretax Income 4.03B 5.69B 6.56B 8.19B 8.78B
Income Tax 787M 1.13B 1.28B 1.35B 1.24B
Income Tax - Current Domestic 1.56B 236M 141M 339M 182M
Income Tax - Current Foreign 389M 670M 934M 1.07B 1.12B
Income Tax - Deferred Domestic (1.15B) 232M 192M (26M) (40M)
Income Tax - Deferred Foreign (7M) (6M) 12M (32M) (14M)
Income Tax Credits 0 0 0 0 -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 3.25B 4.56B 5.28B 6.85B 7.53B
Minority Interest Expense 0 (18M) (50M) (8M) (3M)
Net Income 3.25B 4.57B 5.33B 6.85B 7.54B
Extraordinaries & Discontinued Operations 0 (313M) 776M 0 430M
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 430M
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 (313M) 776M 0 0
Net Income After Extraordinaries 3.25B 4.26B 6.11B 6.85B 7.97B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 3.25B 4.57B 5.33B 6.85B 7.54B
EPS (Basic) 1.98 2.57 3.59 3.99 4.48
Basic Shares Outstanding 1.64B 1.66B 1.7B 1.72B 1.68B
EPS (Diluted) 1.96 2.52 3.51 3.91 4.40
Diluted Shares Outstanding 1.66B 1.69B 1.74B 1.75B 1.71B
EBITDA 3.89B 6.22B 6.82B 8.58B 9.18B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...
Continue Reading
A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...
Continue Reading
A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...
Continue Reading
Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...
Continue Reading
Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...
Continue Reading
AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...
Continue Reading
Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...
Continue Reading
Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...
Continue Reading
A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...
Continue Reading
First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...
Continue Reading
Top 5 Most Recently Viewed Articles
Introduction to LightBox's Findings Recent insights from LightBox reveal significant shifts in the commercial real estate (CRE) sector, highlighting increased activity in response to recent economic changes. As a leading provider of CRE information and technology, LightBox's Monthly CRE Activity Index plays a crucial role in tracking the dynamics of the market....
Continue Reading
Understanding Alliance Pharma's Trading Activity Alliance Pharma plc, known for its strategic positioning in the pharmaceutical market, has made a significant impact through its recent trading activities. These transactions are crucial for understanding the company's current standing and future potential in the market. The firm operates under the stock ticker LSE:INVP,...
Continue Reading
Icon Energy Corp. Welcomes M/V Bravo and Secures Financing Icon Energy Corp. (“Icon”) (Nasdaq: ICON) is thrilled to announce the arrival of its latest fleet member, the M/V Bravo, alongside significant financing aimed at facilitating future growth. This advanced Kamsarmax dry bulk carrier represents a key achievement in Icon's operational strategy, paving the way for...
Continue Reading
Traders braced for turmoil as Coinbase Global, Inc. (NASDAQ: COIN) found itself entangled in a significant class action lawsuit back in 2024, brought forth by the reputable law firm Bronstein, Gewirtz & Grossman. This isn’t just another legal skirmish; it’s an alarm bell ringing loudly for investors who acquired Coinbase securities during the defined Class Period....
Continue Reading
Danny Go! Launches Exciting New Toy Line Three new active-play toys inspired by the beloved YouTube series, Danny Go!, are set to hit shelves just in time for the holiday season. This innovative collaboration between Danny Go! and Just Play, a prominent toy company, aims to engage children through play, song, and dance. Exciting Toy Debut at Walmart The launch of these...
Continue Reading